receptors generally results in reflex vasopressor and sympathoexcitatory responses. [2] [3] [4] In addition to being activated by myocardial ischemia, ventricular receptors are also chemosensitive and can be activated by chemicals such as nicotine (vagal afferents) and bradykinin (sympathetic afferents).
Experimental data from animals and clinical observations in humans indicate that vagal afferents are preferentially distributed to the inferoposterior wall of the left ventricle.5-8 As a result, reflex inhibitory responses are most apparent when stimuli are applied to the inferoposterior left ventricle. Furthermore, experiments performed by Barber and colleagues9 suggest that vagal afferent fibers travel mainly in the deeper endocardial layers of the left ventricle.
In contrast, the study by Barber et al9 indicates that the sympathetic afferent fibers are located mainly in the superficial epicardial layers of the left ventricle.9 Recent data from our laboratory support this observation.'0 We found that excitatory reflexes mediated by cardiac sympathetic afferents in response to coronary occlusion are apparent only when myocardial ischemia is transmural and involves the superficial epicardial layers. Although clinical observations in humans suggest that excitatory responses occur more frequently during ischemia of the anterior left ventricle,7 it has not been determined systematically whether there is a preferential distribution of sympathetic afferents to a particular region of the left ventricle. In our initial experiments, reflex responses were measured only during anterior myocardial ischemia. In the present experiments, we compared reflex responses with regional myocardial ischemia and with chemical stimuli applied to sympathetic afferents in both the anterior and inferoposterior left ventricle to determine whether these receptors are preferentially distributed to a specific region.
Methods
Experiments were performed in 15 anesthetized, mechanically ventilated dogs with cervical vagotomy and sinoaortic denervation. The animals were anesthetized with thiamylal sodium (15- In eight experiments, measurements of arterial and left atrial pressures and renal sympathetic nerve activity were made during epicardial and intracoronary administration of bradykinin. Epicardial bradykinin (mean dose, 143±27 ,ug; range, 100-300 1,g) was applied to 1.5 x 1.5-cm gauze sponges placed on either the anterior or inferoposterior surfaces of the left ventricle. Intra-36°C and 38CC.
coronary bradykinin (mean dose, 59±9 gg; range, 25-100 pug) was injected into either the LAD or LCx through the coronary cannulas. The order in which these maneuvers were performed was randomized. In each experiment, we chose a dose of bradykinin that resulted in a large reflex increase in renal nerve activity. The same dose of bradykinin was administered to the anterior and inferoposterior left ventricle in each experiment. In all cases, adequate time (15-20 minutes) was allowed between each maneuver for stabilization of parameters.
At the completion of six of these experiments, vital stains (6 cm3 of either 1% aniline blue or Ponceau fuchsin solution) were infused through each coronary cannula to demarcate the perfusion bed of each artery. The animal then was killed, and the heart was removed and fixed in 10% formalin. After fixation, the heart was divided into slices 0.5 cm thick, and the stained regions of the left ventricle were separated and weighed to estimate the amount of myocardium exposed to intracoronary bradykinin. Data Analysis
Arterial pressure, left atrial pressure, electroneurogram, and integrated renal nerve activity were recorded continuously on an electrostatic recorder (Gould ES 1000, Gould, Inc., Greenbelt, Md.). Heart rate was measured from the arterial pressure waveforms. In the coronary occlusion experiments, baseline measurements of heart rate, mean arterial and left atrial pressures, and sympathetic nerve activity (impulses per second) were made after the coronary stenosis was adjusted and during the 30-second period that preceded the coronary occlusion. Repeat measurements were made for each 30-second period of the 2-minute coronary occlusion. A final recovery measurement was made 5 minutes after release of the occlusion. In the bradykinin experiments, heart rate, pressure, and nerve activity measurements were made immediately before bradykinin administration and at the time of maximal reflex changes. Since multiunit nerve preparations were used, nerve activity changes were expressed as percent changes from control values. With multiunit preparations, the absolute value of nerve activity is dependent on the number of active fibers placed on the recording electrodes. The number of active fibers may vary widely from one experiment to another. Statistical comparisons between interventions require that nerve activity be normalized to basal values.
Measurements made in each animal were combined, and means±SEM were calculated. Baseline values of mean arterial and left atrial pressures were compared by paired t tests. Analysis of heart rate measurements indicated that the values were not normally distributed. Therefore, baseline heart rate values and maximal changes in heart rate were analyzed by the MannWhitney ranked-sum test. A repeated-measures ANOVA was used to determine whether there were any significant differences in the hemodynamic and nerve activity responses to anterior or inferoposterior myocardial ischemia. In addition, the maximal nerve traffic changes observed during each coronary occlusion were compared by a paired t test. In the bradykinin experiments, the maximal nerve traffic and arterial/left atrial pressure changes observed after intracoronary or epicardial bradykinin administration to the anterior or inferoposterior left ventricle were compared by paired t tests. Paired t tests also were used to compare the weights of myocardium perfused by the coronary cannulas placed into the LAD and LCx. In all cases, a value of p<0.05 was considered statistically significant.
Results

Reflex Responses to Myocardial Ischemia
Baseline values of mean arterial pressure, left atrial pressure, and heart rate measured immediately before each coronary occlusion are shown in Table 1 . There were no significant differences in any of these basal measurements. The changes in mean arterial and left atrial pressures observed during the two coronary occlusions are shown in Figures 1 and 2 ences in the degree of reflex sympathoexcitation elicited by either transmural anterior or transmural inferoposterior myocardial ischemia. The maximal changes in renal nerve activity that occurred during coronary occlusion are shown in Figure 4 . The maximal increase in nerve activity during transmural anterior ischemia (22.6+3.9%) was not significantly different from the maximal nerve traffic increase during transmural inferoposterior ischemia (27.1+4.4%).
Reflex Responses to Epicardial Bradykinin
The maximal changes of renal nerve traffic observed in response to bradykinin applied to the anterior and inferoposterior epicardium are illustrated in Figure 5 . In all cases, epicardial bradykinin elicited large increases in renal nerve activity. Application of bradykinin to the anterior left ventricle resulted in reflex increases in nerve activity that were not significantly different from those observed during application of bradykinin to the inferoposterior wall.
There were no significant differences in baseline pressures or heart rate measured before epicardial bradykinin ( 
Reflex Responses to Intracoronary Bradykinin
Intracoronary bradykinin also elicited large reflex increases in renal sympathetic nerve activity ( Figure 6 ). Injection of bradykinin into the LAD resulted in maximal reflex nerve traffic increases that were not significantly different from the responses observed during injection of bradykinin into the LCx.
In contrast to the effects of bradykinin applied topically, intracoronary injection was associated with significant decreases in mean arterial pressure. During LAD injection, mean arterial pressure decreased from 121+6.6 to 62±4.7 mmHg (p<0.0001). During LCx injection, mean arterial pressure decreased from 119±9.2 to 66±7.6 mm Hg (p<0.0001). There were no significant differences in baseline left atrial pressure or heart rate values measured before each injection (Table  1) . Although small decreases were observed in left atrial pressure after bradykinin injection, these changes were not statistically significant (LAD, -2.2±1.0 mm Hg change; LCx, -2.0±1.0 mm Hg change). There were no significant changes in heart rate associated with intracoronary bradykinin (LAD, 9±4 beats per minute change; LCx, 9±5 beats per minute change).
Estimation of the amount of myocardium exposed to intracoronary bradykinin in six experiments indicated that there was no significant difference in the size of the perfusion beds supplied by either the LAD or LCx coronary cannula (LAD, 40.3±5.7 g; LCx, 35.2±3.3 g). Discussion The major new finding of our study is that left ventricular sympathetic afferents are distributed uniformly in the anterior and inferoposterior walls. This conclusion is based on measurement of reflex responses to receptor activation by three distinct methods -regional transmural myocardial ischemia, regional intracoronary bradykinin injection, and regional epicardial bradykinin application. Reflex excitatory responses mediated by sympathetic afferents were elicited equally by stimuli applied to either the anterior or inferoposterior walls of the left ventricle.
Ventricular receptors with vagal afferents are known to be preferentially distributed to the inferoposterior wall of the left ventricle. This observation is based on experimental data in animals and on clinical observations in humans that indicate that stimuli applied to the inferoposterior left ventricle elicit reflex responses of greater magnitude than do stimuli applied to the anterior left ventricle. For instance, chemical activation of ventricular vagal afferents elicits greater reflex inhibitory responses both in animals and humans when the chemicals are injected into the coronary artery that supplies the inferoposterior wall than when they are injected into the artery that supplies the anterior wall.616 In addition, reflex inhibitory responses associated with myocardial ischemia are larger and are observed more frequently during ischemia involving the inferoposterior wall than during ischemia of the anterior wall.5,78 '17 Although it has not been known previously whether sympathetic afferents are preferentially distributed to a particular region of the left ventricle, some data indicate that sympathetic afferents are located primarily in the superficial epicardial layers. 9 The results of recent experiments from our laboratory support this concept. We demonstrated that reflex excitatory responses could be elicited by myocardial ischemia in dogs if the ischemia was transmural in nature and involved the superficial epicardial layers.'0 Ischemia that was limited mainly to the endocardial layers did not evoke excitatory reflexes. We used our model of transmural myocardial ischemia to test the hypothesis that sympathetic afferents are preferentially distributed in the left ventricle, as are the vagal afferents. We further investigated this possibility by measuring reflex responses to regional epicardial and intracoronary administration of bradykinin. The Similarly, although we did not quantify coronary blood flow during the intracoronary bradykinin experiments, efforts were made to ensure that baseline arterial pressures (and thus coronary perfusion pressures) were similar before each coronary injection. In addition, we quantified the amount of myocardium supplied by the LAD and LCx arterial cannulas; this analysis confirmed that the sizes of the perfusion beds were similar. As a result, it is unlikely that our experimental findings are affected by significant differences in the concentration of bradykinin being injected into each coronary artery or by significant differences in the amount of myocardium being exposed to intracoronary bradykinin.
Although there were differences in the magnitudes of reflex sympathoexcitation elicited by myocardial ischemia and bradykinin administration, we feel that these differences have little physiological significance. The reflex responses to intracoronary and epicardial bradykinin are purely dose dependent. If smaller doses of bradykinin had been administered, then smaller reflex responses would have been elicited, and the responses observed during ischemia and bradykinin would have been of similar magnitude. We used bradykinin as an experimental tool. As such, we administered a dose that would result in a strong stimulus to cardiac sympathetic afferents so that there would be a clearly perceptible change in renal nerve activity.
We observed major differences in the responses of arterial pressure to epicardial and intracoronary bradykinin. Epicardial bradykinin was associated with increases in arterial pressure, whereas intracoronary bradykinin elicited decreases in arterial pressure. These differences probably are related to the route of administration. Both epicardial and intracoronary bradykinin activate ventricular sympathetic afferents and elicit reflex increases in efferent sympathetic nerve activity.
Normally, this reflex sympathoexcitation should increase vascular resistance and elevate arterial pressure, as was observed with epicardial bradykinin. However, bradykinin is a potent vasodilator. We have observed decreases in arterial pressure after intravenous and intra-arterial bradykinin that are similar to those observed after intracoronary bradykinin (unpublished observations). Bradykinin administered by the intracoronary route probably enters the systemic circulation and lowers arterial pressure by a systemic vasodilatory action. In our experiments, this direct vascular effect of bradykinin completely negated the expected effects of augmented sympathetic outflow on vascular resistance and arterial pressure.
In summary, we have demonstrated that there are no significant differences in the excitatory reflexes mediated by ventricular sympathetic afferents in response to ischemic or chemical stimuli applied to either the anterior or inferoposterior left ventricle. This finding indicates that the sympathetic afferents are not preferentially distributed to the anterior or inferoposterior left ventricle. This differs from the vagal afferents, which are located mainly in the inferoposterior wall. Based on this observation, we conclude that there is uniform and equal distribution of sympathetic afferents in the anterior and inferoposterior left ventricle. As a result, we hypothesize that reflex excitatory responses mediated by ventricular sympathetic afferents could occur during clinical ischemic events that involve either the anterior or inferoposterior regions. This is in contrast to the depressor reflexes mediated by the vagal afferents, which are more likely to occur during ischemia of the inferoposterior region.
